Jubiglim MV 1 Tablet SR
Jubiglim MV 1 Tablet SR
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Glimison-VM 1 Tablet SR
Unison Pharmaceuticals Pvt Ltd
Voglibose 0.2mg
Pack Size
1 units
Price
Save ₹105
that's 77% off!
About This Medicine
Product description & overview
Jubiglim MV 1 Tablet SR: A Comprehensive Treatment Solution
Jubiglim MV 1 Tablet SR is a once-daily combination medication designed to manage Type 2 Diabetes Mellitus (T2DM) effectively. This tablet contains Glimepiride (1mg), Metformin (500mg), and Voglibose (0.2mg) – carefully balanced components for comprehensive control of blood sugar levels.
Glimepiride: A sulfonylurea, this component works by stimulating the pancreas to release insulin, reducing glucose production in the liver.
Metformin: A biguanide that helps improve insulin sensitivity and reduces hepatic glucose production, further contributing to reduced glucose levels.
Voglibose: This α-glucosidase inhibitor slows down the absorption of sugars from digested food into the bloodstream, directly impacting postprandial blood sugar spikes.
Jubiglim MV 1 Tablet SR offers a convenient dosage for patients seeking a holistic management approach for T2DM. It is essential to consult with a healthcare professional before starting or changing any medication regimen. This information serves as a general overview and should not be interpreted as medical advice. Always follow the instructions of your doctor or pharmacist for proper use and guidance.
Active composition
Glimepiride 1 mg
+2 more active ingredients
About Glimepiride
Glimepiride is an oral hypoglycemic agent used to manage blood sugar levels in patients with type 2 diabetes mellitus. It works by stimulating the pancreas to release more insulin, thereby lowering blood glucose levels and preventing the symptoms associated with diabetes. Glimepiride is often prescribed alongside diet and exercise to enhance glycemic control and reduce the risk of diabetes-related complications, such as kidney damage and neuropathy. In summary, Glimepiride is an essential medication for controlling blood sugar levels in type 2 diabetes patients.
How It Works
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
All Active Ingredients
Voglibose
Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.
Metformin
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
It is unsafe to consume alcohol with Jubiglim MV 1 Tablet SR.
High Risk
Pregnancy
Jubiglim MV 1 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Driving
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Liver
Jubiglim MV 1 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Jubiglim MV 1 Tablet SR may be needed. Please consult your doctor. Jubiglim MV 1 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Breastfeeding
Jubiglim MV 1 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Kidney
Jubiglim MV 1 Tablet SR is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Jubiglim MV 1 Tablet SR is, however, not recommended in patients with severe kidney disease.
Regular Checkup
Customer Reviews
0 reviews for Jubiglim MV 1 Tablet SR
Products matching your search
Justmet Safe 2 Tablet ER
Justmet Safe 2 Tablet ER
Enzolid 600 Tablet
Enzolid 600 Tablet
Glycilock Trio Forte 2 Tablet SR
Glycilock Trio Forte 2 Tablet SR
Imezemic 500 Tablet
Imezemic 500 Tablet
Zoryl-MF 2 Tablet PR
Zoryl-MF 2 Tablet PR
Edinase-D Tablet
Edinase-D Tablet
Metviron Trio 2mg Tablet
Metviron Trio 2mg Tablet
Clozostrong-DP Dusting Powder